首页> 外文期刊>Drug development and industrial pharmacy >In vitro transungual permeation of ciclopirox from a hydroxypropyl chitosan-based, water-soluble nail lacquer.
【24h】

In vitro transungual permeation of ciclopirox from a hydroxypropyl chitosan-based, water-soluble nail lacquer.

机译:从基于羟丙基壳聚糖的水溶性指甲油中进行环吡酮的体外透皮渗透。

获取原文
获取原文并翻译 | 示例
           

摘要

Commercial antimycotic nail lacquers are commonly based on water-insoluble resins. The present study was aimed at evaluating a novel, experimental nail lacquer (P-3051, Polichem SA, Lugano, Switzerland) based on the water-soluble film-forming agent hydroxypropyl chitosan (HPCH). The in vitro permeation of ciclopirox (CPX) from P-3051 and from a commercial, water-insoluble lacquer based on a vinyl resin (Penlac, Aventis Pharma), was investigated using thin membranes obtained from bovine hooves, an accepted model for human nails. Similar CPX permeation fluxes at steady state through the membranes, but significantly different lag times were observed for P-3051 and Penlac, when these were tested as dry films. The formulations thus appeared to influence only the time required by CPX to saturate the membrane, and not the final drug concentration gradient in the membrane. Permeation experiments performed on the same membranes and on hairless mouse skin with P-3051 and with a similar, HPCH-free vehicle (ERV), both tested in liquid form, disproved the possibility that HPCH might act as a permeation enhancer for CPX in either substrate. The possible reasons for the greater efficiency of the HPCH vehicle in terms of CPX transfer from the vehicle itself to the keratin membrane are discussed. This effect might be tentatively attributed to a particular affinity of HPCH for the membrane, resulting in intimate contact and strong adhesion of the HPCH lacquer to the keratin substrate.
机译:商业抗霉菌指甲油通常基于水不溶性树脂。本研究旨在评估基于水溶性成膜剂羟丙基壳聚糖(HPCH)的新型实验指甲油(P-3051,Polichem SA,瑞士卢加诺)。使用从牛蹄获得的薄膜(人指甲公认的模型)研究了P-3051和基于乙烯基树脂的商用水不溶性漆(Penlac,Aventis Pharma)的环吡酮(CPX)的体外渗透性。在稳定状态下穿过膜的CPX渗透通量相似,但是当将P-3051和Penlac作为干膜进行测试时,观察到显着不同的滞后时间。因此,制剂似乎仅影响CPX使膜饱和所需的时间,而不影响膜中最终的药物浓度梯度。使用P-3051和类似的无HPCH载体(ERV)在相同的膜和无毛小鼠皮肤上进行的渗透实验,均以液体形式进行了测试,这证明了HPCH可能在两种情况下均充当CPX的渗透促进剂基质。讨论了从CPCH从车辆本身到角蛋白膜的转移方面,HPCH车辆效率更高的可能原因。该效果可能暂时归​​因于HPCH对膜的特殊亲和力,导致HPCH漆与角蛋白基质紧密接触并牢固粘附。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号